Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideDoxorubicinTreatment OutcomeNeoadjuvant TherapyDisease-Free SurvivalEtoposideBreast NeoplasmsNeoplasm StagingSurvival AnalysisPrognosisSurvival RateLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmTime FactorsBleomycinNeoplasmsDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyFollow-Up StudiesCarcinoma, Non-Small-Cell LungOvarian NeoplasmsNeoplasm MetastasisTesticular NeoplasmsVomitingTransplantation, AutologousNeutropeniaAdenocarcinomaNauseaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseColorectal NeoplasmsRadiotherapyPhotic StimulationAntibiotics, AntineoplasticDacarbazineDose-Response Relationship, DrugProspective StudiesClinical Trials as TopicNeoplasms, Germ Cell and EmbryonalCarmustineGranulocyte Colony-Stimulating FactorLomustineCamptothecinKaplan-Meier EstimateBrain NeoplasmsPlatinum CompoundsBone NeoplasmsInfusions, Intra-ArterialOsteosarcomaLeukopeniaMelphalanAntiemeticsMitomycinThiotepaLiver NeoplasmsTumor Markers, BiologicalInfusions, IntravenousHematopoietic Stem Cell TransplantationDrug TherapyPeritoneal NeoplasmsMitoxantroneRecurrenceCell Line, TumorLymphatic MetastasisStomach NeoplasmsTegafurPalliative CareAntibodies, Monoclonal, HumanizedGerminomaRadiotherapy DosageDaunorubicinCarcinoma, Squamous CellCarcinomaPrecursor Cell Lymphoblastic Leukemia-LymphomaRandomized Controlled Trials as TopicDisease ProgressionLymphomaLeukemia, Myeloid, Acute